Lineage Cell Therapeutics Inc (LCTX) financials · rev $14.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Lineage Cell Therapeutics Inc (LCTX) rev $14.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $14.6M | $9.50M |
| Cost of Revenue | N/A | $334.0K |
| Gross Profit | N/A | $9.16M |
| Operating Income | -$36.6M | -$21.5M |
| Net Income | -$63.5M | -$18.6M |
| EPS (Diluted) | -$0.28 | -$0.09 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $112.6M | $113.2M |
| Current Assets | $59.2M | $51.0M |
| Cash & Equivalents | $40.8M | $45.8M |
| PP&E | $2.57M | $2.25M |
| Total Liabilities | $69.2M | $36.2M |
| Current Liabilities | $11.4M | $14.0M |
| Shareholders' Equity | $44.5M | $78.4M |
| Retained Earnings | -$467.0M | -$403.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$18.9M | -$23.1M |
| CapEx | $522.0K | $565.0K |
| Investing Cash Flow | -$13.5M | -$2.31M |
| Financing Cash Flow | $26.9M | $35.9M |
| Net Change in Cash | -$5.03M | $10.4M |
| Free Cash Flow | -$19.4M | -$23.7M |
FAQ
What is LCTX P/E and revenue?
Lineage Cell Therapeutics Inc (LCTX) rev $14.6M.
What is LCTX revenue?
Lineage Cell Therapeutics Inc last cached revenue is $14.6M (FY2025).
Is LCTX profitable?
Lineage Cell Therapeutics Inc last cached net income is -$63.5M (FY2025).
What are LCTX total assets?
Lineage Cell Therapeutics Inc last cached total assets are $112.6M (FY2025).
What is LCTX free cash flow?
Lineage Cell Therapeutics Inc last cached free cash flow is -$19.4M (FY2025).
Not investment advice. Cached statements, not a live tape.